Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Morganroth

Showing results (31-40 of 214) with videos related to

Pageof 22
Sort By:
The American Journal of Cardiology|December 1, 1987
Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmiasJ Morganroth
Rational Drug Therapy|April 1, 1987
New antiarrhythmic agents: mexiletine, tocainide, encainide, flecainide, and amiodaroneJ Morganroth
Journal of Clinical Pharmacology|August 1, 1982
Short- and long-term therapeutic efficacy of quinidine sulfate for the treatment of chronic ventricular arrhythmiasI Panidis, J Morganroth
American Heart Journal|December 1, 1985
Comparative efficacy and safety of short-acting and sustained release quinidine in the treatment of patients with ventricular arrhythmiasJ Morganroth, H Hunter
JAMA|June 22, 1970
The need for a medical ideologyA Ruby, J Morganroth
The American Journal of Cardiology|February 15, 1988
Antiarrhythmic effect of a 5-hydroxytryptamine M-receptor antagonist, ICS 205-930J Morganroth, C McGinn
Geriatrics|December 1, 1979
The contributions of ambulatory ECGJ Morganroth, E Michelson
Drug Safety|December 22, 1999
Cardiac effects of ebastine and other antihistamines in humansA J Moss, J Morganroth
Journal of Clinical Pharmacology|February 1, 1995
Effects of food on the bioequivalence of different verapamil sustained-release formulationsS A Waldman, J Morganroth
Cardiology Clinics|May 1, 1986
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatmentP F Nestico, J Morganroth
Pageof 22

Showing results (31-40 of 214) with videos related to

Sort By:
Pageof 22
The American Journal of Cardiology|December 1, 1987
Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmiasJ Morganroth
Rational Drug Therapy|April 1, 1987
New antiarrhythmic agents: mexiletine, tocainide, encainide, flecainide, and amiodaroneJ Morganroth
Journal of Clinical Pharmacology|August 1, 1982
Short- and long-term therapeutic efficacy of quinidine sulfate for the treatment of chronic ventricular arrhythmiasI Panidis, J Morganroth
American Heart Journal|December 1, 1985
Comparative efficacy and safety of short-acting and sustained release quinidine in the treatment of patients with ventricular arrhythmiasJ Morganroth, H Hunter
JAMA|June 22, 1970
The need for a medical ideologyA Ruby, J Morganroth
The American Journal of Cardiology|February 15, 1988
Antiarrhythmic effect of a 5-hydroxytryptamine M-receptor antagonist, ICS 205-930J Morganroth, C McGinn
Geriatrics|December 1, 1979
The contributions of ambulatory ECGJ Morganroth, E Michelson
Drug Safety|December 22, 1999
Cardiac effects of ebastine and other antihistamines in humansA J Moss, J Morganroth
Journal of Clinical Pharmacology|February 1, 1995
Effects of food on the bioequivalence of different verapamil sustained-release formulationsS A Waldman, J Morganroth
Cardiology Clinics|May 1, 1986
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatmentP F Nestico, J Morganroth
Pageof 22